series-c-plus
Stage
2009
Founded
4
Investors
About
Nurix is a biotechnology company that develops drugs targeting the ubiquitin proteasome system to treat cancer and immune disorders.
Explore Nurix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.